
Aerovate Therapeutics Inc
NASDAQ:JBIO

Intrinsic Value
The intrinsic value of one
JBIO
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 10.51 USD,
Aerovate Therapeutics Inc
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Aerovate Therapeutics Inc
JBIO looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if JBIO is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Fundamental Analysis


Revenue & Expenses Breakdown
Aerovate Therapeutics Inc
Balance Sheet Decomposition
Aerovate Therapeutics Inc
Current Assets | 80.1m |
Cash & Short-Term Investments | 78.6m |
Other Current Assets | 1.5m |
Non-Current Assets | 215k |
PP&E | 215k |
Free Cash Flow Analysis
Aerovate Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Aerovate Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-74.3m
USD
|
Operating Income
|
-74.3m
USD
|
Other Expenses
|
4.7m
USD
|
Net Income
|
-69.6m
USD
|
JBIO Profitability Score
Profitability Due Diligence
Aerovate Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Aerovate Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
JBIO Solvency Score
Solvency Due Diligence
Aerovate Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Aerovate Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
JBIO Price Targets Summary
Aerovate Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
JBIO
is 18.36 USD
with a low forecast of 17.17 USD and a high forecast of 19.95 USD.
Dividends
Current shareholder yield for AVTE is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
JBIO
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 10.51 USD,
Aerovate Therapeutics Inc
is
hidden
.